Jose M. Montserrat

TL;DR: In nonsleepy hypertensive patients with OSA, CPAP treatment for 1 year is associated with a small decrease in BP, and this effect is evident only in patients who use CPAP for more than 5.6 hours per night.

TL;DR: Increased overnight hypoxia as a surrogate of OSA severity was associated with increased cancer incidence, and this association seems to be limited to men and patients younger than 65 years of age.

TL;DR: Autoadjusted titration at home and predicted formula titration with domiciliary adjustment can replace standard titration in sleep apnea patients, which could lead to considerable savings in cost and to significant reductions in the waiting list.

TL;DR: CPAP produced a statistically significant reduction in blood pressure in patients with systemic hypertension and obstructive sleep apnoea, and taking into account the prevalence of hypertension and the likelihood of comorbidities, the decrease inBlood pressure, although minimal, may be beneficial.

TL;DR: The results suggest that an abnormal release of PeptLTs in ASA-sensitive asthmatic patients contributes to nasal and bronchial adverse reactions and the lack of effects on PGD2 release suggests that mast cells from ASA-insensitive patients are more sensitive to ASA than those from sensitive asthmatics and healthy subjects.